SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-058780
Filing Date
2024-07-03
Accepted
2024-07-03 06:10:46
Documents
7
Period of Report
2024-07-02

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0208797-6k_immuron.htm 6-K 15875
2 AT THE MARKET OFFERING AGREEMENT, DATED AS OF JULY 2, 2024, BY AND BETWEEN IMMUR ea020879701ex1-1_immuron.htm EX-1.1 215811
3 OPINION OF FRANCIS ABOURIZK LIGHTOWLERS ea020879701ex5-1_immuron.htm EX-5.1 36303
4 GRAPHIC ex5-1_001.jpg GRAPHIC 2947
5 GRAPHIC ex5-1_002.jpg GRAPHIC 3834
6 GRAPHIC ex5-1_003.jpg GRAPHIC 2268
7 GRAPHIC ex5-1_004.jpg GRAPHIC 10895
  Complete submission text file 0001213900-24-058780.txt   297073
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 241098191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)